IL22 and Alzheimer disease: It has been hypothesized that elevated IL-22 and diminished IL-17 expression predominate in the chronic phase of AD; therefore, the early hypothesis describing AD as a Th2-driven disorder should be modified to accommodate the Th22/Tc22 subsets associated with epidermal changes10–12.